-

Calavo Growers Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Calavo Growers, Inc. - CVGW

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Calavo Growers, Inc. (NasdaqGS: CVGW) to Mission Produce, Inc. (NasdaqGS: AVO). Under the terms of the proposed transaction, shareholders of Calavo will receive $14.85 in cash and 0.9790 shares of Mission for each share of Calavo that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-cvgw/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

Contacts

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 960
New Orleans, LA 70163
Lewis S. Kahn
Managing Partner
lewis.kahn@ksfcounsel.com
855-768-1857

Kahn Swick & Foti, LLC

NASDAQ:CVGW

Release Versions

Contacts

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 960
New Orleans, LA 70163
Lewis S. Kahn
Managing Partner
lewis.kahn@ksfcounsel.com
855-768-1857

Social Media Profiles
More News From Kahn Swick & Foti, LLC

Olaplex Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olaplex Holdings, Inc. - OLPX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA. Under the terms of the proposed transaction, shareholders of Olaplex will receive $2.06 in cash for each share of Olaplex that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequ...

Ultragenyx 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 6, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE), if they purchased or otherwise acquired the Company’s securities between August 3, 2023 and December 26, 2025, inclusive (the “Cl...

Molina Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Molina Healthcare, Inc. - MOH

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). On July 23, 2025, the Company reported its financial results for the second quarter ended June 30, 2025 and cut its full-year 2025 earnings guidance, disclosing that “GAAP net income was $4.75 per dilut...
Back to Newsroom